Mylan MYL

  1. All
  2. Commentary
  3. Headlines
    1. Generic drugmaker Teva bids $40 billion for rival Mylan

      Headlines

      Tue, 21 Apr 2015

      TEL AVIV/NEW YORK (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan 's alternate offer to buy Perrigo Co.

    2. UPDATE 2-Generic drugmaker Teva makes $40 billion offer for rival Mylan

      Headlines

      Tue, 21 Apr 2015

      TEL AVIV/NEW YORK, April 21 (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan 's alternate offer to buy Perrigo Co .

    3. Teva declines to comment on report it to make offer for Mylan

      Headlines

      Tue, 21 Apr 2015

      TEL AVIV, April 21 (Reuters) - Shares in generic drugmakers Teva Pharmaceutical Industries and Mylan jumped in pre-market trade in New York on a report from Bloomberg that Teva could make a public...

    4. BRIEF-Teva won't comment on report it plans to make offer for Mylan

      Headlines

      Tue, 21 Apr 2015

      April 21 (Reuters) - Teva Pharmaceutical Industries spokesman:

    5. UPDATE 1- Mylan says merger with Teva would be bad fit

      Headlines

      Fri, 17 Apr 2015

      April 17 (Reuters) - Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.

    6. Momenta Receives Generic Copaxone Approval

      Commentary

      Thu, 16 Apr 2015

      skeptical of other generic Copaxone contenders, and therefore we don't foresee any material change to our thesis for Mylan as a result. We're leaving our moat ratings in place for all of these firms, but generic Copaxone will help diversify

    7. UPDATE 1- Mylan settles Viagra patent litigation with Pfizer

      Headlines

      Mon, 13 Apr 2015

      April 13 (Reuters) - Drugmaker Mylan N.V said it settled a patent litigation with Pfizer Inc related to Viagra, paving the way for the launch of the drug's generic version in the United States once approved.

    8. Mylan settles Viagra patent litigation with Pfizer

      Headlines

      Mon, 13 Apr 2015

      April 13 (Reuters) - Drugmaker Mylan N.V said it settled a patent litigation with Pfizer Inc related to the generic version of Viagra.

    9. Perrigo acquisition could threaten Mylan's investment grade

      Headlines

      Fri, 10 Apr 2015

      NEW YORK, April 10 (IFR) - Drugmaker Mylan is at risk of dropping back into junk territory if it doesn't strike a perfect balance between bond and equity to finance its proposed US$30bn acquisition of healthcare supplier Perrigo, analysts warned.

    « Prev12345Next »
    Content Partners